Skip to content

Author

M. Bozkurt

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Dapagliflozin and ventricular repolarization across heart failure phenotypes.

BACKGROUND Type 2 diabetes mellitus (T2DM) is associated with abnormal ventricular repolarization and increased arrhythmic risk. Sodium-glucose cotransporter-2 (SGLT-2) inhibitors may exert electrophysiological effects beyond glycemic control. We investigated changes in electrocardiographic (ECG) markers of ventricular...

Gülüzar Traş, Fuat Polat, M. Bozkurt et al. · 0 citations
Sep 2026

Network Pharmacology Reveals MAPK- and RTK-mediated Erythropoietic Signalling as a Shared Mechanism of Dapagliflozin and Empagliflozin

Sodium-glucose cotransporter-2 (SGLT-2) inhibitors consistently raise haemoglobin and haematocrit in patients with type 2 diabetes, heart failure and chronic kidney disease, and post-hoc mediation analyses suggest that this haematological shift accounts for a substantial fraction of their cardiovascular benefit. Th...

M. Bozkurt, A. Turunç · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.